FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Yvonne Li

Research Profile

Chemicals & Drugs

Concepts & Ideas

Physiology

Disorders

Genes & Molecular Sequences

Amino Acid Sequences

Anatomy

Cells, Cultured

Co-author Network

Publications

TOP 3
Kristen M Reipas; Amarpal S Cheema; Artem Cherkasov; Nicole Couto; John A Hassell; Sumaiya Islam; Steven J M Jones; Karen Jung; Jennifer H Law; Huifang Li; Yvonne Li; Sandra E Dunn
Luteolin is a novel p90 ribosomal S6 kinase (RSK) inhibitor that suppresses Notch4 signaling by blocking the activation of Y-box binding protein-1 (YB-1).
Jennifer H Law; Yvonne Li; Karen To; Michelle Wang; Arezoo Astanehe; K Lambie; Jaspreet Dhillon; Steven J M Jones; Martin E Gleave; Connie J Eaves; Sandra E Dunn
Molecular decoy to the Y-box binding protein-1 suppresses the growth of breast and prostate cancer cells whilst sparing normal cell viability.
Anna L Stratford; Christopher J Fry; Curtis Desilets; Alastair H Davies; Yong Y Cho; Yvonne Li; Zigang Dong; Isabelle M Berquin; Philippe Roux; Sandra E Dunn
Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Yvonne Li (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Kristen M Reipas; Amarpal S Cheema; Artem Cherkasov; Nicole Couto; John A Hassell; Sumaiya Islam; Steven J M Jones; Karen Jung; Jennifer H Law; Huifang Li; Yvonne Li; Sandra E Dunn
Luteolin is a novel p90 ribosomal S6 kinase (RSK) inhibitor that suppresses Notch4 signaling by blocking the activation of Y-box binding protein-1 (YB-1).
Oncotarget 2013;4(2):329-45.
2010: Jennifer H Law; Yvonne Li; Karen To; Michelle Wang; Arezoo Astanehe; K Lambie; Jaspreet Dhillon; Steven J M Jones; Martin E Gleave; Connie J Eaves; Sandra E Dunn
Molecular decoy to the Y-box binding protein-1 suppresses the growth of breast and prostate cancer cells whilst sparing normal cell viability.
PloS one 2010;5(9):.
2008: Anna L Stratford; Christopher J Fry; Curtis Desilets; Alastair H Davies; Yong Y Cho; Yvonne Li; Zigang Dong; Isabelle M Berquin; Philippe Roux; Sandra E Dunn
Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells.
Breast cancer research : BCR 2008;10(6):R99.
2007: Devki Nandan; Martin Lopez; Fuqiang Ban; Meilan Huang; Yvonne Li; Neil E Reiner; Artem Cherkasov
Indel-based targeting of essential proteins in human pathogens that have close host orthologue(s): discovery of selective inhibitors for Leishmania donovani elongation factor-1alpha.
Proteins 2007;67(1):53-64.
2006: Artem Cherkasov; Fuqiang Ban; Yvonne Li; Magid Fallahi; Geoffrey L Hammond
Progressive docking: a hybrid QSAR/docking approach for accelerating in silico high throughput screening.
Journal of medicinal chemistry 2006;49(25):7466-78.
2005: Artem Cherkasov; Zheng Shi; Yvonne Li; Steven J M Jones; Magid Fallahi; Geoffrey L Hammond
'Inductive' charges on atoms in proteins: comparative docking with the extended steroid benchmark set and discovery of a novel SHBG ligand.
Journal of chemical information and modeling 2005;45(6):1842-53.